C 301
Alternative Names: C-301; Valproic acid/taurineLatest Information Update: 09 Jul 2007
At a glance
- Originator CepTor Corporation
- Class
- Mechanism of Action GABA uptake inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Epilepsy
Most Recent Events
- 01 Mar 2005 Ceptor Corporation is now an independent company
- 20 Jan 2004 Preclinical trials in Epilepsy in USA (unspecified route)